Elevated IAP in critically ill patients associated with increased AKI incidence: a cohort study from the MIMIC-IV database

危重患者腹内压升高与急性肾损伤发生率增加相关:一项来自MIMIC-IV数据库的队列研究

阅读:5

Abstract

Elevated intra-abdominal pressure can engender a spectrum of adverse physiological repercussions in patients, but further research is needed to ascertain whether elevated intra-abdominal pressure exerts significant effects on renal function. The study used MIMIC-IV database to identify critical patients with IAP monitoring. Patients were categorized into Low-IAP and High-IAP groups based on the results of the restricted cubic splines curve, with HR = 1 set at IAP = 16 mmHg. The primary outcome of the study was the occurrence of AKI within 72 h of ICU admission, and secondary outcomes including the rate of CRRT utilization and 28-day all-cause mortality. Cox proportional hazards regression analysis was employed to clarify the relationship between IAP and AKI. A total of 1746 patients were included in our study. Restricted cubic spline analysis demonstrated an increased risk of AKI with higher IAP. Multivariable Cox proportional hazards analysis uncovered a notable correlation between elevated IAP and AKI incidence (HR: 1.40(1.14-1.71)). After adjusting for confounding factors, patients with elevated IAP remained significantly related with AKI (HR: 1.23(1.01-1.52)). The Kaplan-Meier survival curves indicated a significant superior 28-day survival rate for Low-IAP group (the log-rank test p-value was 0.001) and the cumulative risk curve showed a higher demand for CRRT in the High-IAP group (the log-rank test p-value was 0.0028). Augmented intra-abdominal pressure (above 16 mmHg) is significantly associated with a higher incidence of acute kidney injury (AKI) in critically ill patients, along with an increased need for continuous renal replacement therapy (CRRT) and a higher 28-day mortality rate.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。